OGT to develop tumour profiling assay to facilitate personalised cancer treatment
Company receives £1.16m award from the UK’s Technology Strategy Board
24-Jun-2011 -
Oxford Gene Technology (OGT) has announced that it has received a funding award of £1.16 million from the UK government-backed Technology Strategy Board. As part of the project, OGT will develop a tumour profiling assay based on targeted panel enrichment and next generation sequencing (NGS). The ...
cancer
tumor profiling assays